Korea Investment Partners (KIP) is one of Korea's leading venture capital and private equity firms and a wholly owned subsidiary of Korea Investment Holdings. Founded in 1986, the firm targets early- to growth-stage investments across sectors including biotech, healthcare, media, consumer internet, fintech, and semiconductors.
Average disclosed round size is $1254.1M (across 101 rounds with reported amounts).
Portfolio
97
Fund Size
—
Top Stage
Series A
Last 12 Mo
7
Team
Deok Jun Shin
Investment Advisory
Chang Ho Kim
Head of Inv. Mgmt
David Suh
Head of KIP US
Dong Yeob Kim
CIO
Grace Kim
Head of KIP Beijing
Hudson Ho
Head of KIP Shanghai
Hwang Kim
Head of Corp. Mgmt
Hyunsoo Go
Head of Risk Mgmt
Jin Huh
Head of Inv. Division 1
Mahn Soon Hwang
CEO
Min Sik Park
Head of Inv. Division 2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| QQ-Factor | Seed | $24M | Apr 2026 |
 BreezeBio | Series B | — | Feb 2026 |
| QQ-Factor | Seed | $24M | Jan 2026 |
| BBreeze Bio | Series B | $60M | Jan 2026 |
 Open Asset | Seed | — | Jan 2026 |
| RRedrob | Series A | $10M | Nov 2025 |
| PPinetree Therapeutics, Inc. | Series B | $47M | Oct 2025 |
 Qedma | Series A | $26M | Jul 2025 |
 Enerzai | Bridge | $5.6M | May 2025 |
 viAct | Series A | $7.3M | Apr 2025 |
 Tidal Vision | Series B | $140M | Feb 2025 |
 Orum Therapeutics | Unknown | $100M | Jan 2025 |
 Millie | Series A | $12M | Jan 2025 |
 Bitmagic | Seed | $4M | Jul 2024 |
 Twelve Labs | Series B | $50M | Jun 2024 |
 Livein | Series B | $2.6M | May 2024 |
 Labincube | Series A | — | Apr 2024 |
| SStealthmole | Series A | $7M | Mar 2024 |
 Lambda | Series C | $320M | Feb 2024 |
 HyperAccel | Series A | — | Jan 2024 |
 Levit | Series B | $46M | Jun 2023 |
 Indent Corporation | Series A | $8.1M | Mar 2023 |
| Livein | Series B | $8.3M | Jan 2023 |
| Levit | Series B | — | Jan 2023 |
 Toss Bank | Unknown | $154M | Jan 2023 |
Top Co-Investors
Last updated: 7 September 2026